Maike Hofmann

Dr. Maike Hofmann is a research group leader at the Department of Internal Medicine II within the Faculty of Medicine at the University of Freiburg and the Medical Center – University of Freiburg. Her research focuses on immune responses to viral hepatitis, particularly investigating how killer cells of the human immune system combat hepatitis viruses and liver cancer cells. She leads projects in Collaborative Research Centers (SFB) IMPATH, OncoEscape, and TRR 179, addressing immunopathology, oncogene-driven immune escape, and hepatitis virus persistence.

• Affiliations:
• Medical Center – University of Freiburg
• Department of Internal Medicine II

Her recent studies on SARS-CoV-2 revealed insights into memory T cell formation and immune dynamics post-vaccination, published in Nature Medicine and Nature. She received the Heinz Maier-Leibnitz Prize (2022), Germany’s top award for young researchers, and is funded by the Margarete von Wrangell Habilitation Program since 2019.

• Grants:
• Margarete von Wrangell Habilitation Program (2019–present)

Hofmann’s work bridges molecular immunology with clinical applications, emphasizing translational research in infectious diseases and cancer immunology.